Institute for Applied Health Research, School of Health and Life Sciences, Glasgow Caledonian University, Cowcaddens Road, Glasgow G4 0BA, UK.
Respir Med. 2013 Aug;107(8):1172-7. doi: 10.1016/j.rmed.2013.04.004. Epub 2013 May 3.
The risk of case-fatality following hospitalisation for asthma has not been well characterised. We describe trends in 30 day case-fatality following hospitalisation for asthma in adults in Scotland from 1981 to 2009.
Using the Scottish Morbidity Record Scheme (SMR01) with all asthma hospitalisations for adults (≥18 years) with ICD9 493 and ICD10 J45-J46 in the principal diagnostic position at discharge (1981-2009). These data were linked to mortality data from the General Register Office for Scotland (GROS), with asthma case-fatality defined as death within 30 days of asthma admission (in or out of hospital). Logistic regression was used to explore the impact of age, sex, previous asthma admission (in the 12 months prior to hospitalisation), socioeconomic deprivation, year of admission and co-morbidity on 30-day case-fatality.
There were a total of 116,457 asthma hospitalisations; a total of 1000 (0.9%) hospitalisations resulted in a post-admission death (within 30 days of admission). Odds ratios for unadjusted and adjusted case-fatality showed a decreased risk of case-fatality from the mid-1990s onwards when compared to case-fatality in 1981. Advancing age and co-morbid diagnoses of respiratory failure, cancer, renal failure, cor pulmonale, coronary heart disease and respiratory infection were associated with increased likelihood of death.
30 day case-fatality has declined over the last three decades, comparable to case-fatality reported in other parts of the U.K. This decline may be in part due to improved guidelines, protocols and disease management for asthma over the last 30 years. The likelihood of death 30 days following an asthma admission increased with age group and was associated with respiratory failure, renal failure and cancer.
住院治疗哮喘后病死率的风险尚未得到充分描述。我们描述了 1981 年至 2009 年苏格兰成年人因哮喘住院治疗后 30 天病死率的趋势。
使用苏格兰发病率记录方案(SMR01),其中包含所有成人(≥18 岁)因 ICD9 493 和 ICD10 J45-J46 为主诊断的哮喘住院患者(1981-2009 年)。这些数据与苏格兰总登记处(GROS)的死亡率数据相关联,将哮喘病死率定义为哮喘入院后 30 天内死亡(住院或不住院)。使用逻辑回归探讨年龄、性别、既往哮喘入院(入院前 12 个月内)、社会经济贫困程度、入院年份和合并症对 30 天病死率的影响。
共 116457 例哮喘住院患者;共有 1000 例(0.9%)住院患者在入院后死亡(入院后 30 天内)。未经调整和调整后的病死率比值比显示,与 1981 年相比,从 20 世纪 90 年代中期开始,病死率风险降低。年龄增长和合并呼吸衰竭、癌症、肾衰竭、肺心病、冠心病和呼吸道感染的诊断与死亡的可能性增加相关。
在过去的三十年中,30 天病死率有所下降,与英国其他地区报告的病死率相当。这种下降可能部分归因于过去 30 年来哮喘治疗指南、方案和疾病管理的改进。哮喘入院后 30 天内死亡的可能性随着年龄组的增加而增加,并且与呼吸衰竭、肾衰竭和癌症有关。